Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Phase IIb trial of Catalyst's treatment candidate for cocaine addiction reaches target enrollment

May 22, 2012

NIDA grant supports Scripps Research Institute smoking cessation research

May 16, 2012

Vanda Pharmaceuticals acquires tachykinin NK1 receptor antagonist

April 17, 2012

New vaccine shows promise to treat drug addiction

April 13, 2012

Nippon Shinyaku seeks approval of drug for persons with alcohol dependence

March 27, 2012

NME protects human bone marrow progenitor cells against radiation

March 15, 2012

Immunovaccine and Weill Cornell Medical College join to develop anticocaine vaccine

March 13, 2012

Researchers in U.S. design new therapeutics for radiation injury

March 9, 2012

Courtagen and Avaxia join forces to create new assay

March 8, 2012

Tekmira Pharmaceuticals adds new RNAi therapeutic to pipeline

March 5, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...